Table 3.
Response rates according to the modified Response Evaluation Criteria in Solid Tumors.
| Response | Response rates, n (%) | |
|---|---|---|
| Study group(TACE+RFA-S: n = 40) | Control group(TACE-S: n = 40) | |
| Complete response | 6 (15.0) | 1 (2.5) |
| Partial response | 22 (55.0) | 8 (20.0) |
| Stable disease | 6 (15.0) | 16 (40.0) |
| Progressive disease | 5 (12.5) | 14 (35.0) |
Data are numbers of patients, with percentages in parentheses. RFA, radiofrequency ablation; TACE, transarterial chemoembolization; S, sorafenib; “response” is based on the modified Response Evaluation Criteria for Solid Tumors.